ARS Pharmaceuticals, Inc. (SPRY) Class Action Lawsuit (August 2026)

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

In Litigation

3:26cv4469 • August 5, 2026

Class Period Start

March 9, 2026

Class Period End

June 24, 2026

PSLRA Deadline

October 5, 2026

Case Allegations

10b5

Statutes of Repose

Mar 9, 2029

Country

United States

Court

Federal Court

Aug 5, 2026

A securities fraud class action complaint has been filed on behalf of certain investors in ARS Pharmaceuticals, Inc..

Aug 5, 2026

A securities fraud class action complaint has been filed on behalf of certain investors in ARS Pharmaceuticals, Inc..

ARS Pharmaceuticals, Inc. Litigation